We're buying more of this life sciences stock after an earnings-driven decline

United States News News

We're buying more of this life sciences stock after an earnings-driven decline
United States Latest News,United States Headlines
  • 📰 CNBC
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 72%

The stock is under pressure in early trading due to uncertainty around the recovery in a key business.

We're buying 30 shares of Danaher at roughly $199 each. Following Tuesday's trade, Jim Cramer's Charitable Trust will own 550 shares of DHR, increasing its weighting in the portfolio to 4.08% from 3.87%. Danaher reported a better-than-expected third-quarter Tuesday morning, but the stock is under pressure in early trading due to uncertainty around the recovery in its bioprocessing business. For the quarter, Danaher revenues fell 10.5% to $6.87 billion, beating estimates of $6.

Danaher pointed out that its bioprocessing orders were down in the third quarter versus the second quarter and were expected to decline again in the fourth. We pay close attention to orders because they precede sales. Danaher's view that orders will decline over the next two quarters contrasts the upbeat data point its bioprocessing peer Sartorious said last week.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Browns-Colts: Stock Up, Stock DownCleveland escaped Indianapolis with a 39-38 win and it would have been impossible to pull off without a number of key contributions
Read more »

Walgreens stock gets a boost after JP Morgan expresses confidence in new CEOWalgreens stock gets a boost after JP Morgan expresses confidence in new CEOJ.P. Morgan analysts are optimistic about Walgreen's newest CEO saying they are encouraged by his expertise in healthcare services like leading Cigna’s health services organization.
Read more »

US Stock Market's Stellar 2023 Run Under Threat as Bond Vigilantes Make a ComebackUS Stock Market's Stellar 2023 Run Under Threat as Bond Vigilantes Make a ComebackStocks Analysis by James Picerno covering: Vanguard Total Stock Market Index Fund ETF Shares, LPL Financial Holdings Inc, United States 10-Year, SPDR® Bloomberg High Yield Bond ETF. Read James Picerno's latest article on Investing.com
Read more »

Tesla stock hits 4-month low as DoJ range probe adds to list of concernsTesla said the DoJ is looking into claims about vehicle driving range, add to a growing list of investor concerns for the clean energy carmaker.
Read more »

The stock market may be ignoring this 'bad news' as earnings get under wayThe stock market may be ignoring this 'bad news' as earnings get under way‘Stealth stagnation’ has gone under the radar, says BlackRock team
Read more »

Intel stock drops on report Nvidia is working on an ARM-based PC chipIntel stock drops on report Nvidia is working on an ARM-based PC chipIntel currently has the majority of the market for PC chips, with AMD coming in second.
Read more »



Render Time: 2025-03-01 04:19:44